Our Recommendations
New Publications
- NTDs Part 1: Buruli Ulcer, Chagas, Leishmaniasis (2024)
- Leishmaniasis Treatment Market Size, Share, Industry Growth, Trend, Business Opportunities, Challenges, Drivers and Restraint Research Report by 2028 (2022)
- Serious adverse events following treatment of visceral leishmaniasis: A systematic review and meta-analysis (2021)
- Leishmaniasis Key Facts (2022)
- Community-Based Interventions for the Prevention and Control of Cutaneous Leishmaniasis: A Systematic Review (2022)
Filter
32
Featured
Recommendations
2
New Publications
2
Language
Document type
Studies & Reports
11
Guidelines
7
Fact sheets
6
Strategic & Response Plan
3
No document type
3
Training Material
1
Resource Platforms
1
Countries / Regions
Global
15
Latin America and the Carribbean
9
Middle East and North Africa
4
Sudan
4
Asia
3
Brazil
3
Ethiopia
3
South Sudan
3
India
3
Kenya
2
South–East Asia Region
2
East and Southern Africa
2
Bangladesh
2
Greece
2
Somalia
2
Nepal
1
Colombia
1
Mexico
1
Turkey
1
China
1
Syria
1
Iran
1
Albania
1
Senegal
1
Morocco
1
Africa
1
Jordan
1
Saudi Arabia
1
West and Central Africa
1
Western and Central Europe
1
Paraguay
1
North America
1
Tunisia
1
Southern Africa
1
Lebanon
1
Eastern Europe
1
Georgia
1
Iraq
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Toolboxes
Leishmaniasis
17
Studies & Reports
11
Vector control
5
Statistics & Facts
4
NTDs General
4
Overview, Studies & Reports
4
Clinical Aspects & Diagnostics
3
Opportunistic Infections
1
Pharmacy
1
Essential Medicines
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Statistics & Facts
1
Information & Education Material (IEC)
1
MEDBOX Issue Brief no.35: The first issue brief on the NTD Toolbox contains general strategies, roadmaps, key treatment guidelines, reports, and training material on Buruli ulcer, Chagas, and Leishmaniasis.
There are 3 main forms of leishmaniases: visceral (the most serious form because it is almost always fatal without treatment), cutaneous (the most common, usually causing skin ulcers), and mucocutaneous (affecting mouth, nose and throat).
Leishmaniasis is caused by protozoan parasites which are tra...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
Tis first edition describes the standard operating procedures for health products for NTDs amenable to preventive chemotherapy and the medicines donated to treat them. These include albendazole for lymphatic filariasis and soil-transmitted helminthiases; azithromycin for trachoma and yaws; diethylca...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv...
Cutaneous leishmaniasis (CL) is a neglected infectious endemic disease that is transmitted through the bite of a vector insect (sandfly) of the Lutzomyia genus,typical of rural geographical territories, and causes disfiguring skin ulcers and disabilities. It is estimated that CL affects between 600 ...
Leishmaniasis is a vector-borne disease with a wide variety of parasite species, reservoirs, and vectors involved in transmission. It is caused by different species of the protozoa Leishmania and is transmitted to animals and humans through a bite of insects in the Psychodidae family. Its presence i...
Leishmaniasis is a complex vector-borne disease involving in its transmission several species of protozoan parasites called Leishmania, a wide variety of animal reservoirs and phlebotomine sandflies vectors. Cutaneous Leishmaniasis (CL) is the most common form of the disease, and its clinical manife...
High prevalence of target diseases in rural and developing nations, increased prevalence of malnutrition across the globe, lack of hygiene and poor sanitation facilities, Migratory patterns of population, introduction of new chemical entity in the field of therapeutics, favorable government regulati...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
Leishmaniasis is a parasitic disease that is found in parts of the tropics, subtropics, and southern Europe. Leishmaniasis is caused by infection with Leishmania parasites, which are spread by the bite of infected sand flies. There are several different forms of leishmaniasis in people. The most com...
